Beach ghosts and donanemab
Yesterday evening as sundown approached, I looked out a window on the west side of our house and saw a startling headless reflection looking back enquiringly at me. The optics were easily explained: I...
A Tattoo On My Brain Blog
Dispatches from the Land of Alzheimer’s was released today in the US
My second book, Dispatches from the Land of Alzheimer’s, was released today in the US by Cambridge University Press. It is a collection of essays about Alzheimer’s disease that I have written over the last few...
Keys Bags Names Words
On April 2, I will be participating in a panel discussion following a screening of the documentary film Keys Bags Names Words. This event will be held at 7 – 9 pm at the Smith Memorial...
CAA and ARIA revisited
Dr. Steven Greenberg is most likely the most knowledgeable expert in the world concerning cerebral amyloid angiopathy (CAA) and the vascular pathology associated with Alzheimer’s disease. Earlier this week, I had the honor of...
Excerpt from Dispatches From the Land of Alzheimer’s published yesterday in the Daily Mail
Yesterday the Daily Mail published an article based on my new book, Dispatches From the Land of Alzheimer’s. I think the Daily Mail editors did a really good job of organizing excerpts from the book...
Biogen gives up on aducanumab (Aduhelm)
On January 31, Biogen put out a press release indicating that it “plans to reprioritize its resources in Alzheimer’s disease” by halting development and marketing of the anti-amyloid monoclonal antibody aducanumab (Aduhelm). Patients currently...
Dispatches from the Land of Alzheimer’s is now available in the UK
As can be seen in this display window at the Cambridge University Press bookshop, my new book is now available in the UK and Europe. The book release date in the US is currently...
Speaking during an ice storm to a National Academies of Science Committee on Research Priorities for Preventing and Treating Alzheimer’s Disease and Related Dementias
About a month ago, I received an invitation to give a 10-minute talk on January 17 to The National Academies Committee on Research Priorities for Preventing and Treating Alzheimer’s Disease and Related Dementias. This two-day...
Could breaching the blood-brain barrier possibly be useful in treating Alzheimer’s?
Last week in the New England Journal of Medicine, the results of an interesting proof-of-concept study using focused ultrasound to enhance the ability of the anti-amyloid monoclonal antibody aducanumab to cross the blood blood-brain barrier...
Another anti-amyloid monoclonal antibody trial disappoints, but there may still be hope
I last posted on my blog three weeks ago. A few days after that, I came down with what was probably just a bad cold. It was mainly in my chest with a lot of coughing....
Recent Comments